Skip Ribbon Commands
Skip to main content
Sign In

26411 Cell-Free DNA BRAF V600, Blood (BRAFB)

Cell-Free DNA BRAF V600, Blood (BRAFB)
Test Code: BRAFBSO
Synonyms/Keywords

​Melanoma

Cell free DNA

cfDNA

cell-free DNA

circulating tumor DNA

liquid biopsy

BRAF

V600E

V600K

Circulating tumor cells

Useful For

​An alternative to invasive tissue biopsies for the determination of BRAF V600E and V600K alterations

Identification of patients with melanoma who are most likely to benefit from targeted therapies

This test is not intended for serial monitoring of patients with malignant melanoma, evaluating patients with other malignancies, or as a screening test to identify cancer.

Specimen Requirements
Fasting RequiredSpecimen TypePreferred Container/TubeAcceptable Container/TubeSpecimen VolumeSpecimen Minimum Volume
(allows for 1 repeat)
Pediatric Minimum Volume
(no repeat)
​No​Whole BloodStreck Black/Tan Top Tube Kit (T715)Two, 10-mL Streck cell-free DNA (cfDNA) blood collection tubesOne ​10 mL Streck cell-free DNA tube
Collection Processing Instructions

​Only blood collected in Streck cfDNA tubes will be accepted for analysis.

Whole blood will be processed to produce platelet-poor plasma before cfDNA isolation.

Specimen Stability Information
Specimen TypeTemperatureTime
​Whole Blood ​Ambient (preferred)​7 days
​Refrigerated​7 days
Rejection Criteria

​All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.

Interference

​Patients with a negative test result may still harbor a V600E or V600K alteration. Variant testing of a tissue specimen for BRAF alterations should be considered for patients with a negative result with this test.

The limit of detection of this assay for the detection of BRAF V600E and V600K alterations is influenced by the amount of cell-free DNA (cfDNA) in the blood. This is a biological variable that cannot be controlled.

This assay was designed to detect V600E and V600K alterations. The sensitivity for rarer V600 alterations has not been established.

This test has not been clinically validated for use as a tool to monitor response to therapy or for early detection of tumors.

This test cannot differentiate between somatic and germline alterations.

Performing Laboratory Information
Performing LocationDay(s) Test PerformedAnalytical TimeMethodology/Instrumentation
Mayo Clinic Laboratories​​Monday through Friday​5-10 daysDigital Droplet Polymerase Chain Reaction (ddPCR)
Reference Lab
Test Information

​This test evaluates cell-free DNA (cfDNA) in the peripheral blood for the presence of BRAF V600E or V600K alterations in patients with melanoma and can be used to determine if these patients are candidates for targeted therapies.

This test is not validated for serial monitoring of patients with malignant melanoma, nor should it be used for evaluating patients with other malignancies. This test is also not intended as a screening test to identify cancer.

This test evaluates peripheral blood for BRAF alterations in cell-free DNA.

Detection of BRAF alterations in melanoma patients can be used as an alternative for BRAF analysis of tissue.

Current data suggests that the efficacy of BRAF-targeted therapy and anti-MEK therapy in melanoma is limited to patients whose tumors harbor a V600E or V600K alteration.

Reference Range Information

An interpretive report will be provided.

Interpretation

An interpretive report will be provided.

Outreach CPTs
CPTModifier
(if needed)
QuantityDescriptionComments
81210​​1​BRAF, gene analysis, V600 variants
Synonyms/Keywords

​Melanoma

Cell free DNA

cfDNA

cell-free DNA

circulating tumor DNA

liquid biopsy

BRAF

V600E

V600K

Circulating tumor cells

Ordering Applications
Ordering ApplicationDescription
​COM​Cell-Free DNA BRAF V600, Blood (BRAFB)
​Cerner​Cell-Free DNA BRAF V600, Blood (BRAFB)
If the ordering application you are looking for is not listed, contact your local laboratory for assistance.
Specimen Requirements
Fasting RequiredSpecimen TypePreferred Container/TubeAcceptable Container/TubeSpecimen VolumeSpecimen Minimum Volume
(allows for 1 repeat)
Pediatric Minimum Volume
(no repeat)
​No​Whole BloodStreck Black/Tan Top Tube Kit (T715)Two, 10-mL Streck cell-free DNA (cfDNA) blood collection tubesOne ​10 mL Streck cell-free DNA tube
Collection Processing

​Only blood collected in Streck cfDNA tubes will be accepted for analysis.

Whole blood will be processed to produce platelet-poor plasma before cfDNA isolation.

Specimen Stability Information
Specimen TypeTemperatureTime
​Whole Blood ​Ambient (preferred)​7 days
​Refrigerated​7 days
Rejection Criteria

​All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.

Interference

​Patients with a negative test result may still harbor a V600E or V600K alteration. Variant testing of a tissue specimen for BRAF alterations should be considered for patients with a negative result with this test.

The limit of detection of this assay for the detection of BRAF V600E and V600K alterations is influenced by the amount of cell-free DNA (cfDNA) in the blood. This is a biological variable that cannot be controlled.

This assay was designed to detect V600E and V600K alterations. The sensitivity for rarer V600 alterations has not been established.

This test has not been clinically validated for use as a tool to monitor response to therapy or for early detection of tumors.

This test cannot differentiate between somatic and germline alterations.

Useful For

​An alternative to invasive tissue biopsies for the determination of BRAF V600E and V600K alterations

Identification of patients with melanoma who are most likely to benefit from targeted therapies

This test is not intended for serial monitoring of patients with malignant melanoma, evaluating patients with other malignancies, or as a screening test to identify cancer.

Reference Range Information

An interpretive report will be provided.

Interpretation

An interpretive report will be provided.

For more information visit:
Performing Laboratory Information
Performing LocationDay(s) Test PerformedAnalytical TimeMethodology/Instrumentation
Mayo Clinic Laboratories​​Monday through Friday​5-10 daysDigital Droplet Polymerase Chain Reaction (ddPCR)
Reference Lab
For billing questions, see Contacts
Outreach CPTs
CPTModifier
(if needed)
QuantityDescriptionComments
81210​​1​BRAF, gene analysis, V600 variants
For most current information refer to the Marshfield Laboratory online reference manual.